Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9

Journal of Biological Chemistry

Volumn 292, Issue 14, 2017, Pages 5845-5859

  Li, Wen ^a   Hofer, Markus J ^a   Songkhunawej, Pattama ^a   Jung, So Ri ^a   Hancock, Dale ^a   Denyer, Gareth ^a   Campbell, Iain L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CELL CULTURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES; GLYCOPROTEINS; INTERFERONS; SIGNALING; TISSUE; TRANSCRIPTION;

BIOLOGICAL EFFECTS; INTERFERON REGULATORY FACTORS; NEUROLOGICAL DISEASE; SIGNAL PATHWAYS; SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTIONS; SIGNALING PATHWAYS; TRANSGENIC MICE; TYPE I INTERFERONS;

CELL SIGNALING;

INTERFERON; INTERFERON REGULATORY FACTOR 9; STAT1 PROTEIN; STAT2 PROTEIN; ALPHA INTERFERON; INTERFERON STIMULATED GENE FACTOR 3; IRF9 PROTEIN, MOUSE; STAT1 PROTEIN, MOUSE; STAT2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLIAL CELL CULTURE; INTRACELLULAR SIGNALING; MIXED GLIA CELL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; GLIA; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; INTERFERON-ALPHA; INTERFERON-STIMULATED GENE FACTOR 3; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; MICE; MICE, KNOCKOUT; NEUROGLIA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR;

EID: 85017301126     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.756510     Document Type: Article

References (63)

1. González-Navajas, J. M., Lee, J., David, M., and Raz, E. (2012) Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12, 125-135
2. Sadler, A. J., and Williams, B. R. (2008) Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568
3. Seo, Y. J., and Hahm, B. (2010) Type I interferon modulates the battle of host immune system against viruses. Adv. Appl. Microbiol. 73, 83-101
4. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421
5. Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., and Schreiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264
6. Bluyssen, H. A., and Levy, D. E. (1997) Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J. Biol. Chem. 272, 4600-4605
7. Platanias, L. C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386
8. Rani, M. R., and Ransohoff, R. M. (2005) Alternative and accessory pathways in the regulation of IFN-β-mediated gene expression. J. Interferon Cytokine Res. 25, 788-798
9. Durbin, J. E., Hackenmiller, R., Simon, M. C., and Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450
10. Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442
11. Park, C., Li, S., Cha, E., and Schindler, C. (2000) Immune response in Stat2 knockout mice. Immunity 13, 795-804
12. Gil, M. P., Bohn, E., O'Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., and Schreiber, R. D. (2001) Biologic consequences of Stat1-independent IFN signaling. Proc. Natl. Acad. Sci. U.S.A. 98, 6680-6685
13. Ou, R., Zhou, S., Huang, L., and Moskophidis, D. (2001) Critical role for α/β and γ interferons in persistence of lymphocytic choriomeningitis virus by clonal expansion. J. Virol. 75, 8407-8423
14. Perry, S. T., Buck, M. D., Lada, S. M., Schindler, C., and Shresta, S. (2011) STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 7, e1001297
15. + T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. J. Virol. 86, 6932-6946
16. Li, W., Hofer, M. J., Jung, S. R., Lim, S. L., and Campbell, I. L. (2014) IRF7-dependent Type I interferon production induces lethal immunemediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus. J. Virol. 88, 7578-7588
17. Plumlee, C. R., Lee, C., Beg, A. A., Decker, T., Shuman, H. A., and Schindler, C. (2009) Interferons direct an effective innate response to Legionella pneumophila infection. J. Biol. Chem. 284, 30058-30066
18. Abdul-Sater, A. A., Majoros, A., Plumlee, C. R., Perry, S., Gu, A. D., Lee, C., Shresta, S., Decker, T., and Schindler, C. (2015) Different STAT transcription complexes drive early and delayed responses to type I IFNs. J. Immunol. 195, 210-216
19. Blaszczyk, K., Olejnik, A., Nowicka, H., Ozgyin, L., Chen, Y. L., Chmielewski, S., Kostyrko, K., Wesoly, J., Balint, B. L., Lee, C. K., and Bluyssen, H. A. (2015) STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1. Biochem. J. 466, 511-524
20. Lou, Y. J., Pan, X. R., Jia, P. M., Li, D., Xiao, S., Zhang, Z. L., Chen, S. J., Chen, Z., and Tong, J. H. (2009) IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene Gexpression independently of STAT1. Cancer Res. 69, 3673-3680
21. Akwa, Y., Hassett, D. E., Eloranta, M. L., Sandberg, K., Masliah, E., Powell, H., Whitton, J. L., Bloom, F. E., and Campbell, I. L. (1998) Transgenic expression of IFN-α in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J. Immunol. 161, 5016-5026
22. Campbell, I. L., Krucker, T., Steffensen, S., Akwa, Y., Powell, H. C., Lane, T., Carr, D. J., Gold, L. H., Henriksen, S. J., and Siggins, G. R. (1999) Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α. Brain Res. 835, 46-61
23. Wang, J., Schreiber, R. D., and Campbell, I. L. (2002) STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-α in the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 99, 16209-16214
24. Wang, J., Pham-Mitchell, N., Schindler, C., and Campbell, I. L. (2003) Dysregulated sonic hedgehog signaling and medulloblastoma consequent to IFN-α-stimulated STAT2-independent production of IFN-γ in the brain. J. Clin. Invest. 112, 535-543
25. Hofer, M. J., Li, W., Lim, S. L., and Campbell, I. L. (2010) The type I interferon-α mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. J. Neurosci. 30, 1149-1157
26. Campbell, I. L. (2005) Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res. Brain Res. Rev. 48, 166-177
27. Wang, J., and Campbell, I. L. (2005) Innate STAT1-dependent genomic response of neurons to the antiviral cytokine α interferon. J. Virol. 79, 8295-8302
28. Ousman, S. S., Wang, J., and Campbell, I. L. (2005) Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 79, 7514-7527
29. Samarajiwa, S. A., Forster, S., Auchettl, K., and Hertzog, P. J. (2009) INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37, D852-D857
30. Chatterjee-Kishore, M., Wright, K. L., Ting, J. P., and Stark, G. R. (2000) How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19, 4111-4122
31. Cheon, H., and Stark, G. R. (2009) Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl. Acad. Sci. U.S.A. 106, 9373-9378
32. Zimmerman, M. A., Rahman, N. T., Yang, D., Lahat, G., Lazar, A. J., Pollock, R. E., Lev, D., and Liu, K. (2012) Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance. Cancer Res. 72, 4724-4732
33. Zhao, W., Cha, E. N., Lee, C., Park, C. Y., and Schindler, C. (2007) Stat2-dependent regulation of MHC class II expression. J. Immunol. 179, 463-471
34. Meyer, T., Begitt, A., Lödige, I., van Rossum, M., and Vinkemeier, U. (2002) Constitutive and IFN-γ-induced nuclear import of STAT1 proceed through independent pathways. EMBO J. 21, 344-354
35. Banninger, G., and Reich, N. C. (2004) STAT2 nuclear trafficking. J. Biol. Chem. 279, 39199-39206
36. Robertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., Euskirchen, G., Bernier, B., Varhol, R., Delaney, A., Thiessen, N., Griffith, O. L., He, A., Marra, M., Snyder, M., and Jones, S. (2007) Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4, 651-657
37. Testoni, B., Völlenkle, C., Guerrieri, F., Gerbal-Chaloin, S., Blandino, G., and Levrero, M. (2011) Chromatin dynamics of gene activation and repression in response to interferon alpha (IFNα) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2. J. Biol. Chem. 286, 20217-20227
38. Gough, D. J., Messina, N. L., Hii, L., Gould, J. A., Sabapathy, K., Robertson, A. P., Trapani, J. A., Levy, D. E., Hertzog, P. J., Clarke, C. J., and Johnstone, R. W. (2010) Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol. 8, e1000361
39. Gough, D. J., Messina, N. L., Clarke, C. J., Johnstone, R. W., and Levy, D. E. (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166-174
40. Mostafavi, S., Yoshida, H., Moodley, D., LeBoité, H., Rothamel, K., Raj, T., Ye, C. J., Chevrier, N., Zhang, S. Y., Feng, T., Lee, M., Casanova, J. L., Clark, J. D., Hegen, M., Telliez, J. B., et al. (2016) Parsing the interferon transcriptional network and its disease associations. Cell 164, 564-578
41. Santoni, F. A., Hartley, O., and Luban, J. (2010) Deciphering the code for retroviral integration target site selection. PLoS Comput. Biol. 6, e1001008
42. Ghislain, J. J., and Fish, E. N. (1996) Application of genomic DNA affinity chromatography identifies multiple interferon-α-regulated Stat2 complexes. J. Biol. Chem. 271, 12408-12413
43. Bluyssen, H. A., Muzaffar, R., Vlieststra, R. J., van der Made, A. C. J., Leung, S., Stark, G. R., Kerr, I. M., Trapman, J., and Levy, D. E. (1995) Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc. Natl. Acad. Sci. U.S.A. 92, 5645-5649
44. Decker, T., Lew, D.J., and Darnell, J.E., Jr. (1991) Twodistinctα-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene. Mol. Cell Biol. 11, 5147-5153
45. Li, X., Leung, S., Qureshi, S., Darnell, J. E., Jr., and Stark, G. R. (1996) Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J. Biol. Chem. 271, 5790-5794
46. Brierley, M. M., and Fish, E. N. (2005) Functional relevance of the conserved DNA-binding domain of STAT2. J. Biol. Chem. 280, 13029-13036
47. Ghislain, J. J., Wong, T., Nguyen, M., and Fish, E. N. (2001) The interferoninducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J. Interferon Cytokine Res. 21, 379-388
48. Gupta, S., Jiang, M., and Pernis, A. B. (1999) IFN-α activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J. Immunol. 163, 3834-3841
49. Martinez-Moczygemba, M., Gutch, M. J., French, D. L., and Reich, N. C. (1997) Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-α-stimulated transcription factor ISGF3. J. Biol. Chem. 272, 20070-20076
50. Shresta, S., Sharar, K. L., Prigozhin, D. M., Snider, H. M., Beatty, P. R., and Harris, E. (2005) Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 175, 3946-3954
51. Hahm, B., Trifilo, M. J., Zuniga, E. I., and Oldstone, M. B. (2005) Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22, 247-257
52. Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., Al Ghonaium, A., Tufenkeji, H., Frayha, H., Al-Gazlan, S., Al-Rayes, H., et al. (2003) Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388-391
53. Hambleton, S., Goodbourn, S., Young, D. F., Dickinson, P., Mohamad, S. M., Valappil, M., McGovern, N., Cant, A. J., Hackett, S. J., Ghazal, P., Morgan, N. V., and Randall, R. E. (2013) STAT2 deficiency and susceptibility to viral illness in humans. Proc. Natl. Acad. Sci. U.S.A. 110, 3053-3058
54. Duncan, C. J., Mohamad, S. M., Young, D. F., Skelton, A. J., Leahy, T. R., Munday, D. C., Butler, K. M., Morfopoulou, S., Brown, J. R., Hubank, M., Connell, J., Gavin, P. J., McMahon, C., Dempsey, E., Lynch, N. E., Jacques, T. S., Valappil, M., Cant, A. J., Breuer, J., Engelhardt, K. R., Randall, R. E., and Hambleton, S. (2015) Human IFNAR2 deficiency: lessons for antiviral immunity. Sci. Transl. Med. 7, 307ra154
55. Kimura, T., Kadokawa, Y., Harada, H., Matsumoto, M., Sato, M., Kashiwazaki, Y., Tarutani, M., Tan, R. S., Takasugi, T., Matsuyama, T., Mak, T. W., Noguchi, S., and Taniguchi, T. (1996) Essential and non-redundant roles of p48 (ISGF3 γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1, 115-124
56. Carter, S. L., Müller, M., Manders, P. M., and Campbell, I. L. (2007) Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-γ but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55, 1728-1739
57. Mulligan, C., Rochford, J., Denyer, G., Stephens, R., Yeo, G., Freeman, T., Siddle, K., and O'Rahilly, S. (2002) Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J. Biol. Chem. 277, 42480-42487
58. Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., Sturn, A., Snuffin, M., Rezantsev, A., Popov, D., Ryltsov, A., et al. (2003) TM4: a free, open-source system for microarray data management and analysis. BioTechniques 34, 374-378
59. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
60. Huang da, W., Sherman, B. T., Zheng, X., Yang, J., Imamichi, T., Stephens, R., and Lempicki, R. A. (2009) Extracting biological meaning from large gene lists with DAVID. Curr. Protoc. Bioinformatics 10.1002/0471250953. bi1311s27
61. Asensio, V. C., and Campbell, I. L. (1997) Chemokine gene expression in the brain of mice with lymphocytic choriomeningitis. J. Virol. 71, 7832-7840
62. Maier, J., Kincaid, C., Pagenstecher, A., and Campbell, I. L. (2002) Regulation of signal transducer and activator of transcription and suppressor of cytokine signaling gene expression in the brain of mice with astrocytetargeted production of IL-12 and experimental autoimmune encephalomyelitis. Am. J. Pathol. 160, 271-288
63. Ousman, S. S., and Campbell, I. L. (2005) Regulation of murine interferon regulatory factor (IRF) gene expression in the central nervous system determined by multiprobe RNase protection assay. Methods Mol. Med. 116, 115-134